share_log

6-K: Fasenra Recommended for Approval in the EU by CHMP for the Treatment of Eosinophilic Granulomatosis with Polyangiitis

SEC ·  Sep 23 18:48
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.